Optical hazard of solar radiation on the dilated eye Artykuł oryginalny

##plugins.themes.bootstrap3.article.main##

Pawel Wajss

Abstrakt

Administration of drops to dilate pupils is a common medical procedure around the world prior to an eye examination. Drops cause clinically significant dilation of the pupil (mydriasis) and inhibit its response to the visible wavelengths [1, 2]. The energy absorbed by the retina is proportional to the aperture size [3], therefore the risk of a lesion increases with the diameter of the pupil [4]. There are a vast number of approved drugs, which brochures warn patients about potential risks. Not all mentions protecting eyesight from the light [5-7]. None of them indicate the solar radiation, the sun, the sunlight or similar as potential hazard. Within this research, I adopt international standards for artificial light sources [4, 8] to define the safety class and risk group for the solar radiation affecting the dilated eye. The solar radiation is hazardous, following standards' thresholds [4, 8]. I indicate a lack of clarity and a single-minded approach in the drugs' characteristics regarding this specific hazard. I encourage drug producers and medical society to validate this risk.

##plugins.generic.usageStats.downloads##

##plugins.generic.usageStats.noStats##

##plugins.themes.bootstrap3.article.details##

Dział
Leczenie zachowawcze

Bibliografia

1. Details of Medicinal Product. MYDRIA MAC. Online.
2. SPC. PAREMYD. Online.
3. Sliney DH, Freasier BC. Evaluation of optical radiation hazards. Appl Opt. 1973; 12(1): 1-24.
4. Safety of laser products. Part 1: Equipment classification and requirements. International Standard IEC 60825 1:2014. 2014.
5. Prescribing information with consumer information. Mydriacyl. Online.
6. Novartis company. Bula Paciente - Mydriacyl tropicamida 10 mg/ml. Online.
7. Consumer medicine information. Mydriacyl Eye Drops; Tropicamide Ophthalmic Solution 0.5% & 1.0%. Online.
8. Photobiological safety of lamps and lamp systems. International Standard IEC 62471:2006. 2006.
9. opis odsyłaczaNational Renewable Energy Laboratory. Reference Air Mass 1.5 Spectra. Online. https://www.nrel.gov/grid/solar-resource/spectraam1.5.html.
10. Geeraets WJ, Berry ER. Ocular spectral characteristics as related to hazards from lasers and other light sources. Am J Ophthalmol. 1968; 66(1): 15-20.
11. Boettner EA, Wolter JR. Transmission of the Ocular Media. Invest Ophthalmol. 1962; 1: 776-83.
12. Ulotka dołączona do opakowania: informacja dla użytkownika. Cykloftyal, 10 mg/ml, krople do oczu, roztwór; Cyklopentolatu chlorowodorek. Online. .
13. Bundesinstitut für Arzneimittel und Medizinprodukt. Wortlaut der für die Packungsbeilage vorgesehenen Angaben. Gebrauchsinformation: Information für Anwender. Tropa-Stulln. Online.
14. Watts P, O'Duffy D, Riddell C et al. Can I drive after those drops, doctor? Eye. 1998; 12: 963-6.
15. Goel S, Maharajan P, Chua C et al. Driving ability after pupillary dilatation. Eye. 2003; 17: 735-8.
16. HMA. Octanine. Online.
17. James RH, Landry RJ, Walker BN et al. Evaluation of the Potential Optical Radiation Hazards with Led Lamps Intended for Home Use. Health Phys. 2017; 112(1): 11-7.
18. Zissis G, Kitsinelis S, Arexis-Boisson L et al. LEDs and Solid-State Lighting: the potential health issues. Conference: 7th International Conference on Energy Efficiency in Domestic Appliances and Lighting (EEDAL-13). Coimbra 2013.
19. Scientific Committee on Health, Environmental and Emerging Risks. Opinion on Potential risks to human health of Light Emitting Diodes (LEDs). European Commission, 2018.